
1. thromb haemost. 2015 nov;114(5):1038-48. doi: 10.1160/th15-01-0018. epub 2015 jul
9.

protein c system defects inflicted malaria parasite protein pfemp1 
overcome soluble epcr variant.

petersen je(1), bouwens ea, tamayo i, turner l, wang cw, stins m, theander tg,
hermida j, mosnier lo, lavstsen t.

author information: 
(1)jens e. v. petersen, centre medical parasitology, dept. international
health, immunology & microbiology, university copenhagen dept. of
infectious diseases, rigshospitalet, 1014 copenhagen, denmark, tel.: +45
35327549, fax: +45 35327851, e-mail: jevang@sund.ku.dk.

the endothelial protein c receptor (epcr) essential anticoagulant 
cytoprotective functions protein c (pc) system. selected variants the
malaria parasite protein, plasmodium falciparum erythrocyte membrane protein 1
(pfemp1) associated severe malaria, including cerebral malaria, specifically
target epcr vascular endothelial cells. here, examine cellular response
to pfemp1 engagement elucidate role malaria pathogenesis. binding of
the cidrα1.1 domain pfemp1 epcr obstructed activated pc (apc) binding to
epcr induced loss cellular epcr functions. cidrα1.1 severely impaired
endothelial pc activation effectively blocked apc-mediated activation of
protease-activated receptor-1 (par1) associated barrier protective effects of
apc endothelial cells. soluble epcr variant (e86a-sepcr) bound cidrα1.1 with
high affinity interfere (a)pc binding cellular epcr.
e86a-sepcr used decoy capture pfemp1, permitted normal pc activation on
endothelial cells, normal barrier protective effects apc, greatly reduced 
cytoadhesion infected erythrocytes brain endothelial cells. data
imply important contributions pfemp1-induced protein c pathway defects 
pathogenesis severe malaria. furthermore, e86a-sepcr decoy provides a
proof-of-principle strategy development novel adjunct therapies for
severe malaria.

doi: 10.1160/th15-01-0018 
pmid: 26155776  [indexed medline]

